# Parkervision Inc: Form 10-Q for the period ended Mar 31, 2017

- Company: [Parkervision Inc](/companies/prkr.md) (CIK 914139)
- Form: 10-Q
- Filed: 2017-05-15
- Accepted by EDGAR: May 15, 2017, 20:03 ET
- Period: 2017-03-31
- Accession: 0000914139-17-000037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914139/000091413917000037/prkr-20170331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914139/000091413917000037/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2017-01-01 to 2017-03-31 | $1.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-03-31 | $3.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2017-01-01 to 2017-03-31 | $19.5k | us-gaap:InterestExpense |
| Net income | 3 months, 2017-01-01 to 2017-03-31 | −$4.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-01-01 to 2017-03-31 | −$0.32 | us-gaap:EarningsPerShareBasicAndDiluted |
| Capital expenditure | 3 months, 2017-01-01 to 2017-03-31 | $26.5k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2017-03-31 | $1.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $8.5m | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $14.7m | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $2.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-03-31 | $16.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-03-31 | −$2.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 16,454 characters.

#### Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public. This quarterly report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including, in particular, statements about our future plans, objectives, and expectations contained in this Item. When used in this quarterly report and in future filings by us with the Securities and Exchange Commission (“SEC”), the words or phrases “expects”, “will likely result”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements.” Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected, including the risks and uncertainties identified in our annual report on Form 10-K for the fiscal year ended December 31, 2016 (the “Annual Report”) and in this Item 2 of Part I of this quarterly report. Examples of such risks and uncertainties include general economic and business conditions, competition, unexpected changes in technologies and technological advances, the timely development and commercial acceptance of new products and technologies, reliance on key business and sales relationships, reliance on our intellectual property, the outcome of our intellectual property litigation and the ability to obtain adequate financing in the future. We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.

#### Corporate Website

We webcast our earnings calls and certain events we participate in or host with members of the investment community in the investor relations section of our website. Additionally, we announce investor information, including news and commentary about our business, financial performance and related matters, SEC filings, notices of investor events, and our press and earnings releases, in the investor relations section of our website (http://ir.parkervision.com). Investors and others can receive notifications of new information posted in the investor relations section in real time by signing up for email alerts and/or RSS feeds. Further corporate governance information, including our governance guidelines, board committee charters, and code of conduct, is also available in the investor relations section of our website under the heading “Corporate Governance.” The content of our website is not incorporated by reference into this quarterly report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive textual references only.

#### Overview

We are in the business of innovating fundamental wireless technologies and products. We design, develop and market our proprietary radio frequency (“RF”) technologies for use in wireless communication products, including our own internally developed products. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others and therefore our business plan includes enforcement of our intellectual property rights through patent infringement litigation and licensing efforts.

We have a growth strategy that includes wireless product development, manufacturing and sales; intellectual property licensing and enforcement; and acquisition of, or other product ventures with, companies that have businesses that are synergistic with our products and technologies, particularly in the IoT, or Internet of Things, space. We have made significant investments in developing and protecting our technologies and products, the returns on which are dependent upon the generation of future revenues from product sales and/or licensing for realization.

#### Recent Developments

#### Nasdaq Compliance

On April 27, 2017, we received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that we had regained compliance with Listing Rule 5500(b)(2) that relates to the market value of our listed securities (“MVLS”). In January 2017, we were notified by Nasdaq that our MVLS had been below the minimum of $35 million for 30 consecutive business days and therefore we were not in compliance with Nasdaq continued listing standards. We were afforded 180 calendar days, or until July 18, 2017 to regain compliance. This matter is now closed.

#### Liquidity and Capital Resources

At March 31, 2017, our capital resources consisted of approximately $5.9 million in cash, cash equivalents and available-for-sale securities and approximately $0.8 million in restricted cash equivalents. The restricted cash equivalents represents the unused portion of the restricted funds received from BKI.

We used cash for operations of approximately $4.1 million for the three months ended March 31, 2017, representing a $1.9 million, or 31% decrease from cash used for operations for the three months ended March 31, 2016. The decrease is primarily the result of a decrease in payments for litigation fees and expenses which are paid from restricted cash equivalents. Our use of cash for the three months ended March 31, 2017 was largely funded from the proceeds from the sale of our equity securities under an At Market Issuance Sales Agreement. We anticipate an increase in our operating and inventory costs in 2017 as we prepare for the launch of a consumer Wi-Fi product line. We anticipate revenues and margin generated by this consumer product will begin to offset our operating costs in the third quarter of 2017, however it is unlikely that the revenues and margins generated in the short-term will be sufficient to fully fund our operations without the need for additional working capital. Our capital resources at March 31, 2017 are not sufficient to support our working capital requirements for the next twelve months which raises substantial doubt about our ability to continue as a going concern.

Our ability to meet our liquidity needs for the next twelve months is dependent upon (i) our ability to develop, market and sell existing and new products; (ii) our ability to successfully negotiate licensing agreements and/or settlements relating to the use of our technologies by others in excess of our contingent payment obligations; and/or (iii) our ability to obtain additional debt or equity financing. We expect that revenue generated from product sales, patent enforcement actions, and technology licenses over the next twelve months may not be sufficient to cover our working capital requirements. In the event we do not generate sufficient revenues to cover our operational costs and contingent repayment obligations, we will be required to use available working capital and/or raise additional working capital through the sale of equity securities or other financing arrangements.

We expect to continue to invest in patent prosecution and enforcement, product development, and sales, marketing, and customer support for our technologies and products. The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from our technologies and/or products to offset expenses and contingent payment obligations. In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private debt or equity financing or contingent fee arrangements and/or reduce operating costs. Failure to generate sufficient revenues, raise additional capital through debt or equity financings or contingent fee arrangements, and/or reduce operating costs will have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.

#### Results of Operations for Each of the Three Months Ended March 31, 2017 and 2016

We use both generally accepted accounting principles (“GAAP”) and non-GAAP financial measures for assessing our consolidated results of operations. The non-GAAP measures we use include Adjusted Net Loss and Adjusted Net Loss per Share. These non-GAAP measures exclude the effect on net loss and net loss per share of (i) changes in fair value of our secured contingent payment obligation and (ii) share-based compensation expense. Share-based compensation is a non-cash expense item that is subject to significant fluctuation in value based on the volatility of the market price of our common stock, and the expense recognized on a GAAP basis is not necessarily indicative of the compensation realized by our executives, employees and non-employee directors. The change in fair value of our secured contingent payment obligation is subject to significant estimates and assumptions regarding future events and, similar to interest on long-term debt obligations, is a reflection of our cost of financing rather than our operating activities. Accordingly, we consider these non-GAAP measures to provide relevant supplemental information to assist investors in better understanding our operating results. These non-GAAP measures should not be considered a substitute for, or superior to measures of financial performance prepared in accordance with GAAP.

Refer to “Reconciliation of Non-GAAP Financial Measures” in this section for a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the three months ended March 31, 2017 and 2016.

### Revenue and Gross Margin

Our revenue decreased approximately $59,000 during the three month period ended March 31, 2017 when compared to the same period in 2016. Our gross margin decreased approximately $22,000 during the three month period ended March 31, 2017 when compared to the same period in 2016.

For the three months ended March 31, 2016, our revenue consisted primarily of design services and our cost of sales included the cost of materials, labor and overhead incurred under our engineering services contracts.

### Research and Development Expenses

Research and development expenses consist primarily of engineering and related management and support personnel costs; fees for outside engineering design services which we use from time to time to supplement our internal resources; depreciation expense related to our assets used in product development; prototype production and materials costs, which represent the fabrication and packaging costs for prototype integrated circuits, as well as the cost of supporting components for prototype board development; software licensing and support costs, which represent the annual licensing and support maintenance for engineering design and other software tools; and rent and other overhead costs for our engineering design facility. Personnel costs include share-based compensation amounts which have been determined based on the grant date fair value of equity-based awards to our employees and then recorded to expense over the vesting period of the award.

Our research and development expenses increased approximately $933,000, or 140%, during the three months ended March 31, 2017 when compared to the same period in 2016. This is primarily the result of an increase in costs related to integrated circuit design and fabrication of approximately $567,000 and an increase in personnel costs, including share-based compensation, of approximately $285,000. Share-based compensation expense increased approximately $219,000 as a result of new awards granted to engineering executives and employees in August 2016.

### Selling, General, and Administrative Expenses

Selling, general and administrative expenses consist primarily of executive, director, sales and marketing, and finance and administrative personnel costs, including share-based compensation, and costs incurred for insurance, shareholder relations and outside legal and professional services, including litigation expenses.

Our selling, general and administrative expenses decreased approximately $1,094,000 or 25%, during the three months ended March 31, 2017 when compared to the same period in 2016. This is the result of a decrease in litigation fees and expenses of approximately $1,423,000 partially offset by an increase in share-based compensation expense of approximately $409,000.

The decrease in litigation related fees and expenses is primarily related to contingent fee arrangements with our litigation firms. The increase in share-based compensation expense for the three months ended March 31, 2017 is the result of equity awards granted to directors and executives in August 2016.

### Change in Fair Value of Contingent Payment Obligation

We have elected to measure our secured contingent payment obligation at fair value which is based on significant unobservable inputs. We estimated the fair value of our secured contingent payment obligation using an income approach based on the estimated present value of projected future cash outflows using a risk-adjusted discount rate. Increases or decreases in the significant unobservable inputs could result in significant increases or decreases in fair value.

For the three months ended March 31, 2017, the fair value of our secured contingent payment obligation decreased by approximately $167,000. This decrease is a result of changes in the estimated timing and amount of projected future cash outflows resulting from the funded actions.

### Adjusted Net Loss and Adjusted Net Loss Per Share

Adjusted net loss decreased by approximately $0.8 million, or 15%, during the three months ended March 31, 2017 when compared to the same period in 2016. The decrease in adjusted net loss is primarily the result of a decrease in litigation expenses, somewhat offset by increases in development costs. On a per share basis, our adjusted net loss per common share decreased by $0.16 per share, or 36%. This decrease is a result of the decrease in our adjusted net loss and a 32% increase in our weighted average common shares outstanding.

### Reconciliation of Non-GAAP Financial Measures

The following table presents a reconciliation of our net loss to the non-GAAP measure of adjusted net loss for the three months ended March 31, 2017 and 2016, respectively:

*(in thousands)*

|  | Three Months Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Net loss | $(4,809) | $(5,137) |
| Excluded items: |  |  |
| Share-based compensation | 663 | 35 |
| Change in fair value of contingent payment obligation | (167) | 23 |
| Adjusted net loss | $(4,313) | $(5,079) |

The following table presents a reconciliation of our net loss per common share to the non-GAAP measure of adjusted net loss per common share for the three months ended March 31, 2017 and 2016, respectively:

|  | Three Months Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Basic and diluted net loss per common share | $(0.32) | $(0.45) |
| Excluded items on a per share basis | 0.03 | - |
| Adjusted net loss per common share | $(0.29) | $(0.45) |

#### Off-Balance Sheet Transactions, Arrangements and Other Relationships

As of March 31, 2017, we had outstanding warrants to purchase 420,000 shares of our common stock. The estimated grant date fair value of these warrants of $826,006 is included in shareholders’ equity in our consolidated balance sheets. The outstanding warrants have an average exercise price of $2.21 per share and a weighted average remaining life of approximately 4 years.

#### Contractual Obligations

There have been no material changes in our contractual obligations as set forth in our Annual Report, except as follows:

In April 2017, we entered into a new lease agreement for our Lake Mary, Florida facility. The lease term is expected to commence July 1, 2017 and provides for a straight-lined monthly base rental payment of approximately $11,900 through November 2022, with an option for renewal.

#### Critical Accounting Policies

There have been no changes in accounting policies from those stated in our Annual Report.

## Market risk

As filed, 670 characters.

For the three months ended March 31, 2017, there were no material changes from the market risk information disclosed under Item 7A of Part II of our Annual Report. We are exposed to market risk from changes in currency exchange rates that could impact our results of operations and financial position. We have assets and liabilities denominated in non-functional currencies which are remeasured at each reporting period. Any gains or losses recognized for changes in currency exchange rates are included in operating expenses in our consolidated statements of comprehensive loss. We do not consider the market risk from changes in currency exchange rates to be material.

## Controls and procedures

As filed, 945 characters.

#### Evaluation of Disclosure Controls and Procedures

As of March 31, 2017, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures,” as defined in Rule 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of March 31, 2017.

#### Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 395 characters.

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report. In addition to the information in this quarterly report, the risk factors disclosed in our Annual Report should be carefully considered in evaluating our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.

Filed May 15, 2017.
Source: SEC EDGAR, the filing index for accession 0000914139-17-000037. Last ingested by Listed: Nov 11, 2026, 01:56 ET. No prices; not investment advice.
